![]() IPO endeavors as Beijing intensified its policing of technology platforms in China. The news of LinkDoc ran parallel to the decision by Keep to pull its $500 million U.S. ![]() Provide the latest LinkDoc Technology(LDOC) market data, including prices, cycle charts, basic information and real-time news information, financial analysis, company introduction, dividends and dividend information, you can also use Moomoo to open an account to trade LinkDoc Technology stockswe will provide investors with reference decision data. public listings are not forbidden, the move by LinkDoc is expected to spark a pull-out by additional Chinese companies with U.S. The move by officials prompted investors to unload Chinese stocks listed in the U.S.Īnalysts told Reuters that despite the fact that U.S. LinkDoc is likely the first Chinese startup to have retreated from its IPO plans as China’s regulatory agencies stepped up Big Tech oversight. IPO as the fallout from China’s crackdown on data-rich companies listing overseas continues. The move against Didi from Chinese regulators came just two days after it went public in the U.S. Chinese medical data company LinkDoc Technology filed paperwork on Monday to list shares in the US, as China’s digital healthcare industry continues to grow in the wake of the coronavirus pandemic.Alibaba-backed medical data firm LinkDoc Technology Ltd. The company did not disclose a specific value for its offering but listed it in the filing as $100 million, a placeholder figure typically used to calculate registration fees. #Sources didi linkdoc us ipotimes registration ![]() ![]() However, Bloomberg previously reported that the company could raise around $500 million through the IPO, citing unnamed sources.Īccording to its prospectus, LinkDoc Technology’s revenue for 2020 reached $1.07 billion. In the first three months of the year, the firm reported a 41% increase in revenue year-on-year, while net losses widened to 20.7 million yuan ($21.17 million) from 61.6 million yuan ($9.62 million) a year earlier. ![]() As of March 31, the company treated a total of 2.5 million patients, and collaborated with more than 330 hospitals and 39,000 registered physicians.įounded in 2014, the Beijing-based startup serves China’s medical institutions and pharmaceutical companies by providing cancer-focused healthcare services built on big data and artificial intelligence (AI). It operates the country’s largest data-driven digital infrastructure for precision medicine, according to consulting firm Frost & Sullivan, which consists of LinkCare, a digital continuous care platform for patients with critical diseases, LinkData, an AI-enabled curation system for longitudinal medical data, and LinkSolutions, a data-driven precision life sciences solution platform that helps life sciences companies accelerate clinical research and real-world evidence adoption. In its filing, LinkDoc Technology stated it will dedicate 45% of the funds raised in the IPO to strengthen its research and development capacities, improve its technology infrastructure, and recruit more oncologists and data scientists. The startup also said that about 15% of the IPO proceeds will be allocated to expand its patient care center network and service offerings.
0 Comments
Leave a Reply. |